These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3242314)

  • 1. A possible association between survival time and transfusion in cervical cancer.
    Blumberg N; Agarwal MM; Chuang C
    Yale J Biol Med; 1988; 61(6):493-500. PubMed ID: 3242314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood transfusion and the risk of recurrence in stage IB cervical cancer.
    Morris PC; Haugen J; Tomjack J; Anderson B; Buller RE
    Gynecol Oncol; 1995 Jun; 57(3):401-6. PubMed ID: 7774845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does perioperative blood transfusion affect survival in patients with cervical cancer treated with radical hysterectomy?
    Monk BJ; Tewari K; Gamboa-Vujicic G; Burger RA; Manetta A; Berman ML
    Obstet Gynecol; 1995 Mar; 85(3):343-8. PubMed ID: 7862369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of spread in node-positive cervical cancer: the relationship between local control and distant metastases.
    Stock RG; Chen AS; Karasek K
    Cancer J Sci Am; 1996; 2(5):256-62. PubMed ID: 9166542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical significance of blood transfusion at the time of radical hysterectomy.
    Eisenkop SM; Spirtos NM; Montag TW; Moossazadeh J; Warren P; Hendrickson M
    Obstet Gynecol; 1990 Jul; 76(1):110-3. PubMed ID: 2359556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term results of maximally aggressive trimodality therapy in a high-risk subset of early-stage cervical cancer patients.
    Elliott KS; Borowsky ME; Malka ES; Scudder SA; Leiserowitz GS; Russell AH
    J Reprod Med; 2006 May; 51(5):383-8. PubMed ID: 16779984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Posttherapy surveillance of women with cervical cancer: an outcomes analysis.
    Bodurka-Bevers D; Morris M; Eifel PJ; Levenback C; Bevers MW; Lucas KR; Wharton JT
    Gynecol Oncol; 2000 Aug; 78(2):187-93. PubMed ID: 10926801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of local failure in early laryngeal cancer.
    Lohynska R; Slavicek A; Bahanan A; Novakova P
    Neoplasma; 2005; 52(6):483-8. PubMed ID: 16284693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in the demographics and perioperative care of stage IA(2)/IB(1) cervical cancer over the past 16 years.
    Covens A; Rosen B; Murphy J; Laframboise S; DePetrillo AD; Lickrish G; Colgan T; Chapman W; Shaw P
    Gynecol Oncol; 2001 May; 81(2):133-7. PubMed ID: 11330939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stage I cervical adenocarcinoma: prognostic evaluation of surgically treated patients.
    Matthews CM; Burke TW; Tornos C; Eifel PJ; Atkinson EN; Stringer CA; Morris M; Silva EG
    Gynecol Oncol; 1993 Apr; 49(1):19-23. PubMed ID: 8482554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
    Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
    Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of prognostic factors for uterine cervical cancer patients treated with irradiation alone.
    Grigiene R; Valuckas KP; Aleknavicius E; Kurtinaitis J; Letautiene SR
    BMC Cancer; 2007 Dec; 7():234. PubMed ID: 18154683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Could follow-up different modalities play a role in asymptomatic cervical cancer relapses diagnosis? An Italian multicenter retrospective analysis.
    Zola P; Fuso L; Mazzola S; Piovano E; Perotto S; Gadducci A; Galletto L; Landoni F; Maggino T; Raspagliesi F; Sartori E; Scambia G
    Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S150-4. PubMed ID: 17868785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of patients after extraperitoneal lymph node dissection for cervical cancer.
    Denschlag D; Gabriel B; Mueller-Lantzsch C; Tempfer C; Henne K; Gitsch G; Hasenburg A
    Gynecol Oncol; 2005 Mar; 96(3):658-64. PubMed ID: 15721408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors and relapse patterns in early-stage cervical carcinoma after brachytherapy and radical hysterectomy.
    Gerdin E; Cnattingius S; Johnson P; Pettersson B
    Gynecol Oncol; 1994 Jun; 53(3):314-9. PubMed ID: 8206404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of angiogenesis and recurrence-free survival of early stage cervical cancer patients undergoing radical hysterectomy with pelvic lymph node dissection.
    Phoophitphong T; Hanprasertpong J; Dechsukhum C; Geater A
    J Obstet Gynaecol Res; 2007 Dec; 33(6):840-8. PubMed ID: 18001452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of laparascopic-assisted radical vaginal hysterectomy and radical abdominal hysterectomy in the treatment of cervical cancer.
    Steed H; Rosen B; Murphy J; Laframboise S; De Petrillo D; Covens A
    Gynecol Oncol; 2004 Jun; 93(3):588-93. PubMed ID: 15196849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic factors for patients with early cervical cancer treated by radical hysterectomy and postoperative radiotherapy.
    Tsai CS; Lai CH; Wang CC; Chang JT; Chang TC; Tseng CJ; Hong JH
    Gynecol Oncol; 1999 Dec; 75(3):328-33. PubMed ID: 10600284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term improvement in treatment outcome after radiotherapy and hyperthermia in locoregionally advanced cervix cancer: an update of the Dutch Deep Hyperthermia Trial.
    Franckena M; Stalpers LJ; Koper PC; Wiggenraad RG; Hoogenraad WJ; van Dijk JD; Wárlám-Rodenhuis CC; Jobsen JJ; van Rhoon GC; van der Zee J
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1176-82. PubMed ID: 17881144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extent of disease as an indication for pelvic radiation following radical hysterectomy and bilateral pelvic lymph node dissection in the treatment of stage IB and IIA cervical carcinoma.
    Monk BJ; Cha DS; Walker JL; Burger RA; Ramsinghani NS; Manetta A; DiSaia PJ; Berman ML
    Gynecol Oncol; 1994 Jul; 54(1):4-9. PubMed ID: 8020837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.